本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

武田制药

15.13
+0.11000.73%
盘后15.130.00000.00%19:42 EDT
成交量:162.95万
成交额:2,456.54万
市值:472.61亿
市盈率:67.40
高:15.14
开:15.00
低:15.00
收:15.02
数据加载中...
2022/01/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/14

超过5%披露

TAKEDA PHARMACEUTICAL CO LTD
2021/09/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/29

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]